Domesco Medical Import Export JSC (STC:DMC) Operating Income: ₫231,367 Mil (TTM As of Mar. 2026)


STC:DMC Domesco Medical Import Export JSC STC:DMC
78 GF Score
Price ₫58,000.00
GF Value ₫73,733.67
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Domesco Medical Import Export JSC Operating Income?

Domesco Medical Import Export JSC STC:DMC 78 Operating Income is ₫231,367 Mil as of Mar. 2026. GuruFocus rates STC:DMC with a GF Score™ of 78/100 and a GF Value™ of ₫73,733.67 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Domesco Medical Import Export JSC's Operating Income for the three months ended in Mar. 2026 was ₫58,178 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₫231,367 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Domesco Medical Import Export JSC's Operating Income for the three months ended in Mar. 2026 was ₫58,178 Mil. Domesco Medical Import Export JSC's Revenue for the three months ended in Mar. 2026 was ₫519,590 Mil. Therefore, Domesco Medical Import Export JSC's Operating Margin % for the quarter that ended in Mar. 2026 was 11.20%.

Warning Sign:

Domesco Medical Import Export JSC operating margin has been in a 5-year decline. The average rate of decline per year is -5%.

Domesco Medical Import Export JSC's 5-Year average Growth Rate for Operating Margin % was -5.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Domesco Medical Import Export JSC's annualized ROC % for the quarter that ended in Mar. 2026 was 15.76%. Domesco Medical Import Export JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 25.32%.


Domesco Medical Import Export JSC  (STC:DMC) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Domesco Medical Import Export JSC's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=232711.116 * ( 1 - 20% )/( (1168281.205 + 1194256.507)/ 2 )
=186168.8928/1181268.856
=15.76 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1915798.055 - 180674.656 - ( 566842.194 - max(0, 226973.752 - 1694904.999+566842.194))
=1168281.205

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1946596.135 - 172726.85 - ( 579612.778 - max(0, 204904.402 - 1730583.463+579612.778))
=1194256.507

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Domesco Medical Import Export JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=264643.508/( ( (147212.933 + max(875825.55, 0)) + (142010.851 + max(925501.769, 0)) )/ 2 )
=264643.508/( ( 1023038.483 + 1067512.62 )/ 2 )
=264643.508/1045275.5515
=25.32 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(554087.816 + 521235.062 + 27476.424) - (180674.656 + 0 + 46299.096)
=875825.55

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(548983.505 + 553869.32 + 27553.346) - (172726.85 + 0 + 32177.552)
=925501.769

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Domesco Medical Import Export JSC's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=58177.779/519590.348
=11.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Domesco Medical Import Export JSC Operating Income Related Terms


Domesco Medical Import Export JSC Operating Income Historical Data

* Premium members only.

The historical data trend for Domesco Medical Import Export JSC's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Domesco Medical Import Export JSC Operating Income Chart

Domesco Medical Import Export JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 186,404.95 234,483.60 183,443.49 226,028.41 220,800.03

Domesco Medical Import Export JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47,420.41 40,858.47 26,920.48 105,409.86 58,177.78
STC:DMC
78GF Score
Domesco Medical Import Export JSC STC:DMC
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Domesco Medical Import Export JSC Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫231,367 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of ₫231,367 Mil mean?
Domesco Medical Import Export JSC (STC:DMC) has a Operating Income of ₫231,367 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Domesco Medical Import Export JSC and its competitors.
Is Domesco Medical Import Export JSC's Operating Income too high?
Domesco Medical Import Export JSC's current Operating Income is ₫231,367 Mil. Overall, Domesco Medical Import Export JSC has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Domesco Medical Import Export JSC's Operating Income compare to ZTS and UTHR?
Domesco Medical Import Export JSC's Operating Income of ₫231,367 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Drug Manufacturers company?
A good Operating Income depends on the Drug Manufacturers industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Domesco Medical Import Export JSC and its competitors. Domesco Medical Import Export JSC's current Operating Income is ₫231,367 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Domesco Medical Import Export JSC stock overvalued right now?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC (STC:DMC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫73,733.67, compared to a current price of ₫58,000.00 — trading 21.3% below its estimated fair value. The current Operating Income is ₫231,367 Mil. Domesco Medical Import Export JSC's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Domesco Medical Import Export JSC (STC:DMC), the current Operating Income is ₫231,367 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Domesco Medical Import Export JSC (STC:DMC) Overvalued in 2026?

Based on GuruFocus' analysis, Domesco Medical Import Export JSC stock appears to be undervalued. The current stock price of ₫58,000.00 is trading 21.3% below its estimated GF Value™ of ₫73,733.67. GuruFocus considers Domesco Medical Import Export JSC to be Modestly Undervalued.

Key valuation signals for STC:DMC:

  • Operating Income: ₫231,367 Mil
  • GF Value™: ₫73,733.67 vs. price of ₫58,000.00 (21.3% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the STC:DMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Domesco Medical Import Export JSC Business Description

Address No. 346, Nguyen Hue street, My Tra Ward, Cao Lanh City, Dong Thap, VNM
Domesco Medical Import Export JSC is specialized in research, development, production, marketing and trading of Pharmaceuticals, medicines derived from Pharmaceutical materials, functional food, pure drinking water and medical beverages. It operates in import and export of medicines, medicine materials, food - functional foods, medical supplies, and medical equipment for medical examination and treatment for the whole people.
78GF Score

Get the complete analysis for STC:DMC

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫58,000.00
Price
₫73,733.67
GF Value